Sanofi announces $396m vaccine manufacturing facility in Toronto

(adsbygoogle = window.adsbygoogle || []).push({}); French pharma company Sanofi has announced a new vaccine manufacturing facility in Toronto to be built with an investment of CAD500 million ($396.3 million) at the Canadian headquarters of its vaccine business unit Sanofi Pasteur. Sanofi says that the investment in the new vaccine manufacturing More...

by businessnewstoday | Published 8 months ago
By businessnewstoday On Saturday, April 14th, 2018
0 Comments

Alexion to acquire Swedish pharma company Wilson Therapeutics for $855m

Pharma acquisition news : US-based Alexion Pharmaceuticals through an all-cash deal of SEK7.1 billion ($855 million) will acquire Wilson Therapeutics, a Swedish pharma company focused on developing drugs for rare More...

By businessnewstoday On Saturday, April 14th, 2018
0 Comments

GSK offloads rare disease gene therapy drugs to Orchard Therapeutics

Pharma acquisition news : British drug company GlaxoSmithKline (GSK) has agreed to transfer its rare disease gene therapy drugs to Orchard Therapeutics for an equity stake of 19.9% and a seat on the board of the More...

By businessnewstoday On Monday, April 9th, 2018
0 Comments

Novartis to buy US gene therapy company AveXis for $8.7bn

Novartis acquisition of AveXis : Swiss pharma company Novartis has struck a $8.7 billion deal to acquire US gene therapy company AveXis in a move to bolster its gene therapy and neuroscience pipeline. Novartis Acquisition More...

By businessnewstoday On Wednesday, March 28th, 2018
0 Comments

GSK to buy out Novartis’ stake in consumer healthcare JV for $13bn

Pharma acquisition news : GlaxoSmithKline (GSK) has agreed to buy out Swiss pharma company Novartis’ stake of 36.5% in their consumer healthcare joint venture (JV) for a price of $13 billion, just days after pulling More...

By businessnewstoday On Saturday, March 24th, 2018
0 Comments

GSK, Reckitt Benckiser pull out from $20bn race to acquire Pfizer’s consumer healthcare business

Pharma acquisition news : In a blow to Pfizer’s plans to offload its consumer healthcare business for about $20 billion, both Reckitt Benckiser and now GlaxoSmithKline (GSK) have pulled out from potential acquisition More...

By businessnewstoday On Friday, March 16th, 2018
0 Comments

Danish pharma company Lundbeck to buy Parkinson’s drug developer Prexton

Pharma acquisition news : Danish pharma company Lundbeck has reached an agreement, expected to be worth around $1.1 billion, to acquire Prexton Therapeutics, a Swiss pharma company focused on Parkinson’s drug More...

By businessnewstoday On Monday, March 12th, 2018
0 Comments

Biogen to acquire Pfizer neurology drug in a deal that could reach $600m

Pharma acquisition news : US biotechnology company Biogen has made a deal with Pfizer to buy the latter’s neurology drug candidate PF-04958242, which is being developed for the treatment of a symptom associated More...

By businessnewstoday On Thursday, February 22nd, 2018
0 Comments

US pharma giant Merck to buy Australian biotech company Viralytics for $394m

Merck acquisition of Viralytics : US pharma giant Merck has made an AUD 502 million ($394 million) deal to acquire Viralytics, an Australian biotech company focused on developing oncolytic immunotherapy treatments More...

By businessnewstoday On Sunday, February 18th, 2018
0 Comments

HECL to distribute Cardax astaxanthin dietary supplement ZanthoSyn in China

Cardax, a Hawaii-based pharma company has inked a purchase agreement with Hong Kong-based Health Elite Club (HECL) for distribution of ZanthoSyn, its astaxanthin dietary supplement for inflammatory health and longevity, More...